| Line item | 2025-09-30 FY | 2025-06-30 FY | 2025-03-31 FY | 2024-12-31 FY | 2024-09-30 FY | 2024-06-30 FY | 2024-03-31 FY | 2023-12-31 FY |
|---|---|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – | – | – |
| Operating Expenses | $363.08M | $98.83M | $80.36M | $75.69M | $242.09M | $62.14M | $55.88M | $55.75M |
| R&D | – | – | – | – | – | – | – | – |
| SG&A | – | – | – | – | – | – | – | – |
| Operating Income | – | – | – | – | – | – | – | – |
| Interest Expense | – | – | – | – | – | – | – | – |
| Tax Expense | – | – | – | – | – | – | – | – |
| Net Income | $35.55B | $5.06B | $14.27B | -$604.33M | $20.36B | $3.02B | $3.92B | $5.27B |
| EPS (basic) | 111.1300 | 15.4300 | 46.1800 | -1.9800 | 69.0200 | 10.4600 | 13.4000 | 17.4400 |
| EPS (diluted) | – | – | – | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – | – | – | – |